http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010005836-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e25a8eafd8fb5ba8dc565471b34dc96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5634e75b27034e19a7d4eca864aaadf7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
filingDate 2009-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_029f2bb78d6783c8a90517c4aff8d9e8
publicationDate 2010-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010005836-A3
titleOfInvention Use of rifalazil to treat colonic disorders
abstract Methods for treating bacterial infections in the colon, and colonic disorders caused by bacterial infection, using a poorly absorbable form of Rifalazil, are described. Compositions for oral administration, and colonic delivery, of a non- microgranulated Rifalazil formulation, are also described. Rifalazil is delivered in a form which is poorly absorbed in the gut after oral dosing, and the vast majority of the orally-dosed Rifalazil is not absorbed in the gut. Accordingly, the antibacterial potency in the colonic flora will be enhanced, while absorption and systemic circulation will be reduced, thus reducing potential adverse events.
priorityDate 2008-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5547683-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004019907-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426117527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135431094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226455621

Total number of triples: 23.